Your browser doesn't support javascript.
loading
Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study.
Harrison, Stephen A; Manghi, Federico Perez; Smith, William B; Alpenidze, Diana; Aizenberg, Diego; Klarenbeek, Naomi; Chen, Chi-Yi; Zuckerman, Eli; Ravussin, Eric; Charatcharoenwitthaya, Phunchai; Cheng, Pin-Nan; Katchman, Helena; Klein, Samuel; Ben-Ari, Ziv; Mendonza, Anisha E; Zhang, Yiming; Martic, Miljen; Ma, Shenglin; Kao, Sheena; Tanner, Sandra; Pachori, Alok; Badman, Michael K; He, YanLing; Ukomadu, Chinweike; Sicard, Eric.
Afiliação
  • Harrison SA; Pinnacle Clinical Research, San Antonio, Texas, USA. sharrison@pinnacleresearch.com.
  • Manghi FP; CINME, Buenos Aires, Argentina.
  • Smith WB; Alliance for Multispecialty Research, The University of Tennessee Medical Center, Knoxville, TN, USA.
  • Alpenidze D; City Outpatient Clinic #117, St. Petersburg, Russia.
  • Aizenberg D; Centro Medico Viamonte, Buenos Aires, Argentina.
  • Klarenbeek N; Centre for Human Drug Research, Leiden, the Netherlands.
  • Chen CY; Chia-Yi Christian Hospital, Chiayi City, Taiwan.
  • Zuckerman E; Carmel Medical Center, Haifa, Israel.
  • Ravussin E; Pennington Biomedical Research Center, Baton Rouge, LA, USA.
  • Charatcharoenwitthaya P; Siriraj Hospital, Bangkok, Thailand.
  • Cheng PN; National Cheng Kung University Hospital, Tainan City, Taiwan.
  • Katchman H; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Klein S; Washington University School of Medicine, St. Louis, MO, USA.
  • Ben-Ari Z; Sheba Medical Center, Ramat Gan, Israel.
  • Mendonza AE; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Zhang Y; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Martic M; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Ma S; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Kao S; Novartis Institutes for BioMedical Research, Pudong Shanghai, China.
  • Tanner S; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Pachori A; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Badman MK; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • He Y; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Ukomadu C; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Sicard E; Altasciences Algorithme Pharma, Quebec, Canada.
Nat Med ; 28(7): 1432-1438, 2022 07.
Article em En | MEDLINE | ID: mdl-35725922
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article